Publication date: 10 February 2016
Source:Vaccine, Volume 34, Issue 7
Author(s): Philip S. Watson, David P.J. Turner
Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults. Vaccines have been successfully introduced to help protect against meningococcal disease caused by serogroups A, C, W and Y, but until recently, a vaccine for serogroup B (MenB) was not available. In many industrialised countries, MenB causes the majority of meningococcal disease. Moreover, MenB outbreaks occur unpredictably, particularly in high-risk populations, such as university students. In 2013, Bexsero® became the first broad-coverage vaccine to be licensed for active immunisation against MenB disease. Bexsero is now licensed in more than 35 countries worldwide for varying age groups, including the EU, Australia, Brazil, Canada, Chile, Uruguay and the USA.Clinical recommendations for the use of Bexsero have been published in several countries. Recommendations include use in high-risk groups, outbreak control and routine infant immunisation. Since initial licensure, considerable clinical experience has been gained. In Canada, 43,740 individuals received Bexsero during a vaccination programme in the Saguenay–Lac-Saint-Jean region of Quebec, where local disease incidence was high. In the USA, Bexsero was administered to >15,000 individuals during two college outbreaks prior to licensure, under an Investigational New Drug protocol. In the UK, the Joint Committee on Vaccination and Immunisation has recommended the inclusion of Bexsero in the routine immunisation schedule for infants. Publically funded vaccination programmes have been initiated in Italy, and there has been widespread use of the vaccine outside of publically reimbursed programmes. Overall, >1,000,000 doses of Bexsero have been distributed in 19 countries worldwide since 2013.The emerging clinical experience with Bexsero is consistent with findings from pre-licensure clinical studies, and no new safety concerns have been identified. Additional data on length of protection, potential impact on meningococcal carriage and transmission and strain coverage have also been published and will be reviewed.
from #Medicine via ola Kala on Inoreader http://ift.tt/1SCfRQV
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
-
▼
Φεβρουαρίου
(793)
-
▼
Φεβ 02
(50)
- A needs assessment of people living with diabetes ...
- Research participation after terrorism: an open co...
- Quantification of low molecular weight selenium me...
- GC-induced tethered repression need GR SUMOylation...
- GC-induced direct repression needs GR SUMOylation ...
- Detection of patterns in sound sequences [Neurosci...
- Spectral structure of intrinsic networks [Neurosci...
- A slow growth bacterial transcription factor [Micr...
- Subunit arrangement in a GluClR [Physiology]
- Correction for Sohl et al., Probing the structural...
- Correction to Supporting Information for Rosenzwei...
- Correction for Ling et al., Extremely high genetic...
- Correction for Ogasawara et al., Rapid and profoun...
- Social regulation of gene expression in zebrafish ...
- Latent EBV sensing via exosomal small RNA transfer...
- T-cell-intrinsic Tif1{alpha}/Trim24 regulates alle...
- MINCR is a MYC-induced lncRNA [Biological Sciences]
- TCF7L1 in HP axis development [Developmental Biology]
- Structure of NDP-forming Ac-CoA synthetase [Bioche...
- Seafood Consumption, Mercury, and Brain Neuropatho...
- National Cluster-Randomized Trial of Duty-Hour Fle...
- Establishment of Genome-edited Human Pluripotent S...
- Stem cell-like Xenopus Embryonic Explants to Study...
- Successful diagnosis of intrahepatic splenosis mim...
- Toward Optimum Benefit-Risk and Reduced Access Lag...
- Distribution patterns of stone-tool reduction: Est...
- La duplication rectale de l’adulte : une cause exc...
- Place de la coloscopie dans la prévention et le dé...
- Facteurs de risque d’hémorragies digestives par ru...
- Dual-Frequency Alternating Current Designer Wavefo...
- Detection of Borrelia burgdorferi sensu lato and s...
- Identification and characterization of Theileria o...
- An updated distribution and hosts: trombiculid mit...
- Antenatal immunisation intentions of expectant par...
- Editorial Board/Aims and Scope
- Clinical experience with the meningococcal B vacci...
- Impact of a publicly funded monovalent rotavirus v...
- Can thermostable vaccines help address cold-chain ...
- A trivalent vaccine candidate against hepatitis E ...
- Intradermal vaccination with un-adjuvanted sub-uni...
- Adverse events following immunization in patients ...
- Infant vaccination timing: Beyond traditional cove...
- Evaluation of the non-toxic mutant of the diphther...
- Immunogenicity and efficacy of alphavirus-derived ...
- The Use of Aspiration Catheter Systems for Embolic...
- Recombinant Brain Natriuretic Peptide for the Prev...
- Development of a Murine Infection Model with Leish...
- The Synthesis and Evaluations of the 68Ga-Lissamin...
- Evaluation of Hepatotoxicity with Treatment Doses ...
- Clinical Effect and Mechanism of Yisui Shengxue Gr...
-
▼
Φεβ 02
(50)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.